fda compounding semaglutide news today 2025 restricts non-approved compounded GLP-1 weight loss products What Patients Need to Know

Description

Metabolic Adaptation Is Associated With a Greater Increase in Appetite Following Weight Loss: A Longitudinal Study

This is especially important for women and anyone over 40, populations where muscle preservation during weight loss is critical for long-term metabolic health

Tightening of pricing and market access, an increase in competitive intensity, unexpected safety signals, or manufacturing supply constraints within the GLP-1/GIP space could have a significant impact on their overall R&D returns

The prevalence of HFpEF is rising, increasing from 33 to 39% between 2005 and 2010, with projections suggesting it will soon become the most common form of HF [5, 6]

Mechanism of Action Peptide Sciences Retatrutide Retatrutide binds and activates three key receptors involved in metabolic regulation: GIP Receptor Agonism: Enhances insulin secretion and promotes nutrient storage GLP-1 Receptor Agonism: Reduces appetite, delays gastric emptying, and supports glucose control Glucagon Receptor Agonism: Increases energy expenditure and fat oxidation This multi-target synergy mimics physiological hormone cascades, offering superior therapeutic potential compared to single-receptor agents